Trial Profile
A phase II, multicenter, randomized, double-blind, placebo-controlled trial of aramchol in patients with Non Alcoholic Steatohepatitis (NASH) also suffering from obesity and insulin resistance
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2015
Price :
$35
*
At a glance
- Drugs Icomidocholic acid (Primary)
- Indications Fatty liver
- Focus Therapeutic Use
- Sponsors Galmed Pharmaceuticals
- 25 Feb 2015 Results published in Galmed Pharmaceuticals media release.
- 08 Sep 2014 New trial record